Quick answer In the REDEFINE trials CagriSema is given once weekly by subcutaneous injection, with both components titrated in parallel from 0.25 mg + 0.25 mg up to a 2.4 mg + 2.4 mg weekly target
If you're experiencing sudden, patchy or rapid hair loss, please see a healthcare provider - that's a medical question, not a skincare one, and a cosmetic is not a substitute for proper diagnosis
We noted mixed momentum signals: buyers showed strength in the rally, but oscillators pointed to potential exhaustion without fresh catalysts, leaving near-term upside dependent on a decisive technical break
Input the desired dose (mg or mcg)
Improved Skin Texture: Helps repair damaged skin cells, leading to smoother, more supple, and hydrated skin